Rescue of deficient amygdala tonic γ‐aminobutyric acidergic currents in theFmr–/ymouse model of fragile X syndrome by a novel γ‐aminobutyric acid type A receptor‐positive allosteric modulator
- 26 August 2015
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 94 (6) , 568-578
Abstract
Alterations in the ratio of excitatory to inhibitory transmission are emerging as a common component of many nervous system disorders, including autism spectrum disorders (ASDs). Tonic γ‐aminobutyric acidergic (GABAergic) transmission provided by peri‐ and extrasynaptic GABA type A (GABAA) receptors powerfully controls neuronal excitability and plasticity and, therefore, provides a rational therapeutic target for normalizing hyperexcitable networks across a variety of disorders, including ASDs. Our previous studies revealed tonic GABAergic deficits in principal excitatory neurons in the basolateral amygdala (BLA) in theFmr1–/yknockout (KO) mouse model fragile X syndrome. To correct amygdala deficits in tonic GABAergic neurotransmission inFmr1–/yKO mice, we developed a novel positive allosteric modulator of GABAAreceptors, SGE‐872, based on endogenously active neurosteroids. This study shows that SGE‐872 is nearly as potent and twice as efficacious for positively modulating GABAAreceptors as its parent molecule, allopregnanolone. Furthermore, at submicromolar concentrations (≤1 μM), SGE‐872 is selective for tonic, extrasynaptic α4β3δ‐containing GABAAreceptors over typical synaptic α1β2γ2 receptors. We further find that SGE‐872 strikingly rescues the tonic GABAergic transmission deficit in principal excitatory neurons in theFmr1–/yKO BLA, a structure heavily implicated in the neuropathology of ASDs. Therefore, the potent and selective action of SGE‐872 on tonic GABAAreceptors containing α4 subunits may represent a novel and highly useful therapeutic avenue for ASDs and related disorders involving hyperexcitability of neuronal networks.Keywords
Funding Information
- Sage Therapeutics, Inc.
This publication has 69 references indexed in Scilit:
- Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmissionNature, 2012
- Hyperconnectivity and Slow Synapses during Early Development of Medial Prefrontal Cortex in a Mouse Model for Mental Retardation and AutismCerebral Cortex, 2012
- Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for DiseaseNeuron, 2012
- Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypesNature, 2010
- mRNA and Protein Levels for GABAAα4, α5, β1 and GABABR1 Receptors are Altered in Brains from Subjects with AutismJournal of Autism and Developmental Disorders, 2010
- Control of hippocampal gamma oscillation frequency by tonic inhibition and excitation of interneuronsNature Neuroscience, 2009
- Neurosteroid Replacement Therapy for Catamenial EpilepsyNeurotherapeutics, 2009
- The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampusThe Journal of Physiology, 2007
- Variations on an inhibitory theme: phasic and tonic activation of GABAA receptorsNature Reviews Neuroscience, 2005
- The mGluR theory of fragile X mental retardationTrends in Neurosciences, 2004